skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 27,500  for All Library Resources

Sorted by: Sorted by: Date-newestOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Database: Free E- Journals remove subject: Science & Technology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer
Material Type:
Article 		Add to My Research

Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer

British journal of cancer, 2024-06, Vol.130 (10), p.1599-1608 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-024-02610-0 ;PMID: 38519706

Full text available

Citations Cited by
2
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION
Material Type:
Article 		Add to My Research

Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION

British journal of cancer, 2024-06, Vol.130 (10), p.1679-1686 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-024-02615-9 ;PMID: 38575731

Full text available

Citations Cited by
3
Radiation Reveal: Moving from research engagement to involvement
Radiation Reveal: Moving from research engagement to involvement
Material Type:
Article 		Add to My Research

Radiation Reveal: Moving from research engagement to involvement

British journal of cancer, 2024-06, Vol.130 (10), p.1593-1598 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-024-02648-0 ;PMID: 38615107

Full text available

Citations Cited by
4
Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality
Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality
Material Type:
Article 		Add to My Research

Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality

British journal of cancer, 2024-06, Vol.130 (10), p.1697-1708 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-024-02645-3 ;PMID: 38499728

Full text available

Citations Cited by
5
Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer
Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer
Material Type:
Article 		Add to My Research

Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer

British journal of cancer, 2024-06, Vol.130 (10), p.1709-1715 [Peer Reviewed Journal]

2024. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-024-02651-5 ;PMID: 38491175

Full text available

Citations Cited by
6
Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma
Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma
Material Type:
Article 		Add to My Research

Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma

British journal of cancer, 2024-06, Vol.130 (10), p.1609-1620 [Peer Reviewed Journal]

2024. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-024-02635-5 ;PMID: 38605247

Full text available

Citations Cited by
7
Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling
Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling
Material Type:
Article 		Add to My Research

Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling

British journal of cancer, 2024-06, Vol.130 (10), p.1716-1724 [Peer Reviewed Journal]

2024. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-024-02644-4 ;PMID: 38658783

Full text available

Citations Cited by
8
Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts
Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts
Material Type:
Article 		Add to My Research

Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts

Lupus science & medicine, 2024-05, Vol.11 (1), p.e001158 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-001158 ;PMID: 38789277

Full text available

Citations Cited by
9
iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus
iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus
Material Type:
Article 		Add to My Research

iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus

Lupus science & medicine, 2024-05, Vol.11 (1), p.e000673 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-000673 ;PMID: 38782493

Full text available

Citations Cited by
10
Heart disease in pregnancy and risk of pre-eclampsia: a Swedish register-based study
Heart disease in pregnancy and risk of pre-eclampsia: a Swedish register-based study
Material Type:
Article 		Add to My Research

Heart disease in pregnancy and risk of pre-eclampsia: a Swedish register-based study

Open heart, 2024-05, Vol.11 (1), p.e002728 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002728 ;PMID: 38782544

Full text available

Citations Cited by
11
Development and validation of a risk scoring system to identify patients with lupus nephritis in electronic health record data
Development and validation of a risk scoring system to identify patients with lupus nephritis in electronic health record data
Material Type:
Article 		Add to My Research

Development and validation of a risk scoring system to identify patients with lupus nephritis in electronic health record data

Lupus science & medicine, 2024-05, Vol.11 (1), p.e001170 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-001170 ;PMID: 38769054

Full text available

Citations Cited by
12
Positive psychosocial factors may protect against perceived stress in people with systemic lupus erythematosus with and without trauma history
Positive psychosocial factors may protect against perceived stress in people with systemic lupus erythematosus with and without trauma history
Material Type:
Article 		Add to My Research

Positive psychosocial factors may protect against perceived stress in people with systemic lupus erythematosus with and without trauma history

Lupus science & medicine, 2024-05, Vol.11 (1), p.e001060 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-001060 ;PMID: 38754905

Full text available

Citations Cited by
13
Epidemiology of SLE in Italy: an observational study using a primary care database
Epidemiology of SLE in Italy: an observational study using a primary care database
Material Type:
Article 		Add to My Research

Epidemiology of SLE in Italy: an observational study using a primary care database

Lupus science & medicine, 2024-05, Vol.11 (1), p.e001162 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-001162 ;PMID: 38744457

Full text available

Citations Cited by
14
Multiple polygenic risk scores can improve the prediction of systemic lupus erythematosus in Taiwan
Multiple polygenic risk scores can improve the prediction of systemic lupus erythematosus in Taiwan
Material Type:
Article 		Add to My Research

Multiple polygenic risk scores can improve the prediction of systemic lupus erythematosus in Taiwan

Lupus science & medicine, 2024-05, Vol.11 (1), p.e001035 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-001035 ;PMID: 38724181

Full text available

Citations Cited by
15
SF-36v2 and FACIT-Fatigue quality of life improvements with organ-specific SELENA-SLEDAI response and belimumab treatment in patients with systemic lupus erythematosus
SF-36v2 and FACIT-Fatigue quality of life improvements with organ-specific SELENA-SLEDAI response and belimumab treatment in patients with systemic lupus erythematosus
Material Type:
Article 		Add to My Research

SF-36v2 and FACIT-Fatigue quality of life improvements with organ-specific SELENA-SLEDAI response and belimumab treatment in patients with systemic lupus erythematosus

Lupus science & medicine, 2024-05, Vol.11 (1), p.e001118 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-001118 ;PMID: 38724182

Full text available

Citations Cited by
16
Frequency of sarcopenia in Turkish women with systemic lupus erythematosus
Frequency of sarcopenia in Turkish women with systemic lupus erythematosus
Material Type:
Article 		Add to My Research

Frequency of sarcopenia in Turkish women with systemic lupus erythematosus

Lupus science & medicine, 2024-05, Vol.11 (1), p.e001204 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-001204 ;PMID: 38724183

Full text available

Citations Cited by
17
Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension
Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension
Material Type:
Article 		Add to My Research

Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension

Open heart, 2024-05, Vol.11 (1), p.e002710 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002710 ;PMID: 38719497

Full text available

Citations Cited by
18
Heterogeneity of right ventricular echocardiographic parameters in systemic lupus erythematosus among four clinical subgroups, as stratified by clinical organ involvement in observational cohort
Heterogeneity of right ventricular echocardiographic parameters in systemic lupus erythematosus among four clinical subgroups, as stratified by clinical organ involvement in observational cohort
Material Type:
Article 		Add to My Research

Heterogeneity of right ventricular echocardiographic parameters in systemic lupus erythematosus among four clinical subgroups, as stratified by clinical organ involvement in observational cohort

Open heart, 2024-05, Vol.11 (1), p.e002615 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002615 ;PMID: 38702088

Full text available

Citations Cited by
19
Discontinuation of long-term growth hormone treatment in adults with growth hormone deficiency: a survey of UK practice
Discontinuation of long-term growth hormone treatment in adults with growth hormone deficiency: a survey of UK practice
Material Type:
Article 		Add to My Research

Discontinuation of long-term growth hormone treatment in adults with growth hormone deficiency: a survey of UK practice

Endocrine Connections, 2024-05, Vol.13 (5), p.1-10 [Peer Reviewed Journal]

ISSN: 2049-3614 ;EISSN: 2049-3614 ;DOI: 10.1530/EC-23-0533 ;PMID: 38513362

Full text available

Citations Cited by
20
Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial
Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial
Material Type:
Article 		Add to My Research

Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial

British journal of cancer, 2024-05, Vol.130 (9), p.1434-1440 [Peer Reviewed Journal]

2024. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-024-02652-4 ;PMID: 38472421

Full text available

Citations Cited by

Results 1 - 20 of 27,500  for All Library Resources

Sorted by: Sorted by: Date-newestOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1964  (78)
  2. 1964 To 1978  (481)
  3. 1979 To 1993  (1,727)
  4. 1994 To 2009  (9,198)
  5. After 2009  (16,018)
  6. More options open sub menu

Resource Type 

  1. Articles  (27,151)
  2. Reviews  (178)
  3. magazinearticle  (171)
  4. More options open sub menu

Subject 

  1. Life Sciences & Biomedicine  (27,087)
  2. Humans  (25,987)
  3. Adult  (24,917)
  4. Female  (22,246)
  5. Male  (19,057)
  6. Middle Aged  (18,522)
  7. Aged  (13,115)
  8. Oncology  (12,010)
  9. Biological And Medical Sciences  (8,701)
  10. Medical Sciences  (8,364)
  11. Young Adult  (6,134)
  12. Adolescent  (5,920)
  13. Aged, 80 And Over  (5,453)
  14. Immunology  (5,319)
  15. Infectious Diseases  (5,238)
  16. Aids/hiv  (4,175)
  17. Prognosis  (4,082)
  18. Hiv  (3,826)
  19. Risk Factors  (3,797)
  20. More options open sub menu

Language 

  1. English  (27,252)
  2. Japanese  (2,921)
  3. Spanish  (402)
  4. Chinese  (39)
  5. Russian  (9)
  6. Korean  (7)
  7. Norwegian  (5)
  8. Portuguese  (4)
  9. French  (2)
  10. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait